938
Views
160
CrossRef citations to date
0
Altmetric
Perspective

Opportunities and challenges of developing thermostable vaccines

&
Pages 547-557 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (15)

Umit Kartoglu & Henry Ames. (2022) Ensuring quality and integrity of vaccines throughout the cold chain: the role of temperature monitoring. Expert Review of Vaccines 21:6, pages 799-810.
Read now
Ravinder Kumar, Vartika Srivastava, Piyush Baindara & Aijaz Ahmad. (2022) Thermostable vaccines: an innovative concept in vaccine development. Expert Review of Vaccines 21:6, pages 811-824.
Read now
Bhaskar N. Thorat, Ayantika Sett & A. S. Mujumdar. (2022) Drying of Vaccines and Biomolecules. Drying Technology 40:3, pages 461-483.
Read now
Badriyah Shadid Alotaibi, Manal Buabeid, Nihal Abdalla Ibrahim, Zelal Jaber Kharaba, Munazza Ijaz & Ghulam Murtaza. (2021) Recent strategies driving oral biologic administration. Expert Review of Vaccines 20:12, pages 1587-1601.
Read now
Tong Shao & Yong Ye. (2020) Research on Cold-chain Visualization Based on Knowledge Mapping. Science & Technology Libraries 39:3, pages 307-323.
Read now
Tauheed Hasan, Kritika Kumari, Sagolsem Chandrika Devi, Jaya Handa, Tabish Rehman, Nasim Akhtar Ansari & Laishram Rajendrakumar Singh. (2019) Osmolytes in vaccine production, flocculation and storage: a critical review. Human Vaccines & Immunotherapeutics 15:2, pages 514-525.
Read now
Gaurav Kanojia, Rimko ten Have, Peter C. Soema, Henderik Frijlink, Jean-Pierre Amorij & Gideon Kersten. (2017) Developments in the formulation and delivery of spray dried vaccines. Human Vaccines & Immunotherapeutics 13:10, pages 2364-2378.
Read now
Michael Stevenson. (2017) PATH: pioneering innovation for global health at the public–private interface. Third World Quarterly 38:8, pages 1873-1893.
Read now
Kazuaki Uehara, Tatsuaki Tagami, Itaru Miyazaki, Norikazu Murata, Yoshifumi Takahashi, Hiroshi Ohkubo & Tetsuya Ozeki. (2015) Effect of X-ray exposure on the pharmaceutical quality of drug tablets using X-ray inspection equipment. Drug Development and Industrial Pharmacy 41:6, pages 953-958.
Read now
Kristina Jonsson-Schmunk & Maria A Croyle. (2015) A long-lasting, single-dose nasal vaccine for Ebola: a practical armament for an outbreak with significant global impact. Expert Review of Anti-infective Therapy 13:5, pages 527-530.
Read now
Umit Kartoglu & Julie Milstien. (2014) Tools and approaches to ensure quality of vaccines throughout the cold chain. Expert Review of Vaccines 13:7, pages 843-854.
Read now
Manvi Hasija, Lillian Li, Nausheen Rahman & Salvador F Ausar. (2013) Forced degradation studies: an essential tool for the formulation development of vaccines. Vaccine: Development and Therapy 3, pages 11-33.
Read now
Nikolas T Weissmueller, Heiko A Schiffter & Andrew J Pollard. (2013) Intradermal powder immunization with protein-containing vaccines. Expert Review of Vaccines 12:6, pages 687-702.
Read now
Anne L Bishop & Andrew Camilli. (2011) Vibrio cholerae: lessons for mucosal vaccine design. Expert Review of Vaccines 10:1, pages 79-94.
Read now
Moses O Oyewumi, Amit Kumar & Zhengrong Cui. (2010) Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses. Expert Review of Vaccines 9:9, pages 1095-1107.
Read now

Articles from other publishers (145)

Friederike Eilts, Yasmina M.J. Harsy, Keven Lothert, Felix Pagallies, Ralf Amann & Michael W. Wolff. (2023) An investigation of excipients for a stable Orf viral vector formulation. Virus Research 336, pages 199213.
Crossref
Friederike Eilts, Jennifer J. Labisch, Sabri Orbay, Yasmina M.J. Harsy, Marleen Steger, Felix Pagallies, Ralf Amann, Karl Pflanz & Michael W. Wolff. (2023) Stability studies for the identification of critical process parameters for a pharmaceutical production of the Orf virus. Vaccine 41:32, pages 4731-4742.
Crossref
Esen Andiç-Mortan & Cigdem Gonul Kochan. (2023) Modeling a closed-loop vaccine supply chain with transshipments to minimize wastage and threats to the public: a system dynamics approach. Journal of Humanitarian Logistics and Supply Chain Management 13:2, pages 216-234.
Crossref
Amit Kumar Yadav & Dinesh Kumar. (2022) A LAG-based framework to overcome the challenges of the sustainable vaccine supply chain: an integrated BWM–MARCOS approach. Journal of Humanitarian Logistics and Supply Chain Management 13:2, pages 173-198.
Crossref
Julia Sacherl, Anna D. Kosinska, Kristina Kemter, Martin Kächele, Sabine C. Laumen, Hélène A. Kerth, Edanur Ates Öz, Lisa S. Wolff, Jinpeng Su, Sandra Essbauer, Gerd Sutter, Martin Scholz, Katrin Singethan, Jens Altrichter & Ulrike Protzer. (2023) Efficient stabilization of therapeutic hepatitis B vaccine components by amino-acid formulation maintains its potential to break immune tolerance. JHEP Reports 5:2, pages 100603.
Crossref
Amit Kumar Yadav, Shweta & Dinesh Kumar. (2023) Blockchain technology and vaccine supply chain: Exploration and analysis of the adoption barriers in the Indian context. International Journal of Production Economics 255, pages 108716.
Crossref
Darin Zehrung, Courtney Jarrahian & Manjari Lal. 2023. Plotkin's Vaccines. Plotkin's Vaccines 1397 1431.e18 .
Cordin ArpagausCordin Arpagaus. 2023. Spray Drying of Vaccines. Spray Drying of Vaccines 531 589 .
Cordin ArpagausCordin Arpagaus. 2023. Spray Drying of Vaccines. Spray Drying of Vaccines 325 530 .
Cordin ArpagausCordin Arpagaus. 2023. Spray Drying of Vaccines. Spray Drying of Vaccines 33 79 .
Kendall B. Preston, Teri Ann S. Wong, Michael M. Lieberman, Albert To, Chih-Yun Lai, Alex Granados, Holly Thomasson, John Misamore, Jake Yalley-Ogunro, Mehtap Cabus, Hanne Andersen, Oreola Donini, Axel T. Lehrer & Theodore W. Randolph. (2022) Lyophilized Filovirus Glycoprotein Vaccines: Peroxides in a Vaccine Formulation with Polysorbate 80–Containing Adjuvant are Associated with Reduced Neutralizing Antibody Titers in Both Mice and Non-Human Primates. Journal of Pharmaceutical Sciences 111:12, pages 3424-3434.
Crossref
Tomoya Hayashi, Fumika Nakagawa, Yoshitaka Ohno, Yusuke Suzuki, Honatsu Ishiki, Risako Onodera, Taishi Higashi, Yoshihisa Shimamura, Hiroshi Itou, Yoichiro Iwase, Hidetoshi Arima & Keiichi Motoyama. (2022) Antigen stabilizing hydrogels based on cyclodextrins and polyethylene glycol act as type-2 adjuvants with suppressed local irritation. European Journal of Pharmaceutics and Biopharmaceutics 181, pages 113-121.
Crossref
Kaushal Jerajani, Ying Wan, John M. Hickey, Ozan S. Kumru, Nitya Sharma, Swathi R. Pullagurla, Oluwadara Ogun, Shweta Mapari, Neal Whitaker, Sarah Brendle, Neil D. Christensen, Saurabh Batwal, Mustafa Mahedvi, Harish Rao, Vikas Dogar, Rahul Chandrasekharan, Umesh Shaligram, Sangeeta B. Joshi & David B. Volkin. (2022) Analytical and Preformulation Characterization Studies of Human Papillomavirus Virus-Like Particles to Enable Quadrivalent Multi-Dose Vaccine Formulation Development. Journal of Pharmaceutical Sciences 111:11, pages 2983-2997.
Crossref
Kawthar K. Abla & Mohammed M. Mehanna. (2022) Freeze-drying: A flourishing strategy to fabricate stable pharmaceutical and biological products. International Journal of Pharmaceutics 628, pages 122233.
Crossref
Nugroho Agung Pambudi, Alfan Sarifudin, Indra Mamad Gandidi & Rahmat Romadhon. (2022) Vaccine cold chain management and cold storage technology to address the challenges of vaccination programs. Energy Reports 8, pages 955-972.
Crossref
Yu-Jiun Lin & Haichen Nie. (2022) A novel approach to mechanical characterization of pharmaceutical lyospheres. Powder Technology 410, pages 117868.
Crossref
Zahra Ghaemmaghamian, Reza Zarghami, Gavin Walker, Emmet O’Reilly & Ahmad Ziaee. (2022) Stabilizing vaccines via drying: Quality by design considerations. Advanced Drug Delivery Reviews 187, pages 114313.
Crossref
Yu Shang, Li Li, Tengfei Zhang, Qingping Luo, Qingzhong Yu, Zhe Zeng, Lintao Li, Miaomiao Jia, Guoyi Tang, Sanlin Fan, Qin Lu, Wenting Zhang, Yuhan Xue, Hongling Wang, Wei Liu, Hongcai Wang, Rongrong Zhang, Chan Ding, Huabin Shao & Guoyuan Wen. (2022) Quantitative regulation of the thermal stability of enveloped virus vaccines by surface charge engineering to prevent the self-aggregation of attachment glycoproteins. PLOS Pathogens 18:6, pages e1010564.
Crossref
Mina Mehanny, Annette Boese, Behnoosh Bornamehr, Jessica Hoppstädter, Volker Presser, Alexandra K. Kiemer, Claus-Michael Lehr & Gregor Fuhrmann. (2022) Spray-dried pneumococcal membrane vesicles are promising candidates for pulmonary immunization. International Journal of Pharmaceutics 621, pages 121794.
Crossref
Poornima Kalyanram, Anu Puri & Anju Gupta. (2021) Thermotropic effects of PEGylated lipids on the stability of HPPH-encapsulated lipid nanoparticles (LNP). Journal of Thermal Analysis and Calorimetry 147:11, pages 6337-6348.
Crossref
Karen Alejandra Garduño-González, Samantha Ayde Peña-Benavides, Rafael G. Araújo, Carlos Castillo-Zacarías, Elda M. Melchor-Martínez, Mariel Araceli Oyervides-Muñoz, Juan Eduardo Sosa-Hernández, Saul Purton, Hafiz M.N. Iqbal & Roberto Parra-Saldívar. (2022) Current challenges for modern vaccines and perspectives for novel treatment alternatives. Journal of Drug Delivery Science and Technology 70, pages 103222.
Crossref
Ruhani Singh, Jacinta F. White, Malisja de Vries, Gary Beddome, Meiling Dai, Andrew G. Bean, Xavier Mulet, Daniel Layton & Cara M. Doherty. (2022) Biomimetic metal-organic frameworks as protective scaffolds for live-virus encapsulation and vaccine stabilization. Acta Biomaterialia 142, pages 320-331.
Crossref
Angela Fanelli, Luca Mantegazza, Saskia Hendrickx & Ilaria Capua. (2022) Thermostable Vaccines in Veterinary Medicine: State of the Art and Opportunities to Be Seized. Vaccines 10:2, pages 245.
Crossref
Deep Bhattacharya, Chris Wiley, Aaron Latal & Vamsi Krishna. 2022. Practical Aspects of Vaccine Development. Practical Aspects of Vaccine Development 207 224 .
Young Hun Chung, Derek Church, Edward C. Koellhoffer, Elizabeth Osota, Sourabh Shukla, Edward P. Rybicki, Jonathan K. Pokorski & Nicole F. Steinmetz. (2021) Integrating plant molecular farming and materials research for next-generation vaccines. Nature Reviews Materials 7:5, pages 372-388.
Crossref
Haiyue Xu, Tuhin Bhowmik, Kevin Gong, Thu Ngoc Anh Huynh, Robert O. WilliamsIIIIII & Zhengrong Cui. (2021) Thin-film freeze-drying of a bivalent Norovirus vaccine while maintaining the potency of both antigens. International Journal of Pharmaceutics 609, pages 121126.
Crossref
Miao Dong, Natalie M. Meinerz, Kathryne D. Walker, Robert L. Garcea & Theodore W. Randolph. (2021) Thermostability of a trivalent, capsomere-based vaccine for human papillomavirus infection. European Journal of Pharmaceutics and Biopharmaceutics 168, pages 131-138.
Crossref
Tianran Ren, Jun Ren, Ben Matellini, Samuel Tammas-Williams & Wu Ouyang. (2021) The trend of modern cold chain management: Characteristics, challenges and opportunities of vaccine logistics. The trend of modern cold chain management: Characteristics, challenges and opportunities of vaccine logistics.
Abel B. Ekiri, Bryony Armson, Kehinde Adebowale, Isabella Endacott, Erika Galipo, Ruth Alafiatayo, Daniel L. Horton, Adah Ogwuche, Olorunsola N. Bankole, Hussein M. Galal, Beatty-Viv Maikai, Mariana Dineva, Aliyu Wakawa, Erik Mijten, Gabriel Varga & Alasdair J. C. Cook. (2021) Evaluating Disease Threats to Sustainable Poultry Production in Africa: Newcastle Disease, Infectious Bursal Disease, and Avian Infectious Bronchitis in Commercial Poultry Flocks in Kano and Oyo States, Nigeria. Frontiers in Veterinary Science 8.
Crossref
Kendall B. Preston, Teri Ann S. Wong, Albert To, Taylor E. Tashiro, Michael M. Lieberman, Alex Granados, Karen Feliciano, John Harrison, Jake Yalley-Ogunro, Hanne Andersen Elyard, Oreola Donini, Axel T. Lehrer & Theodore W. Randolph. (2021) Single-vial filovirus glycoprotein vaccines: Biophysical characteristics and immunogenicity after co-lyophilization with adjuvant. Vaccine 39:39, pages 5650-5657.
Crossref
R.E. Guktur, E.I. Nep, O. Asala, P.O Olorunfemi, N.C. Ngwuluka, N.A. Ochekpe & A.S. Sagay. (2021) Carboxymethylated and acetylated xerogel derivatives of Plectranthus esculentus starch protect Newcastle disease vaccines against cold chain failure. Vaccine 39:34, pages 4871-4884.
Crossref
Bhavesh PatelPradeep GolaniSanjay A. NagdevHimani JaisinghaniMiss.Miss. & RP MishraDrDr. (2021) HIGHLIGHTS OF COVID VACCINE ERA'S IN LOW ASSETNATIONS.. INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH, pages 36-40.
Crossref
Yoshitaka Nakauchi, Suguru Nishinami & Kentaro Shiraki. (2021) Glass-like protein condensate for the long-term storage of proteins. International Journal of Biological Macromolecules 182, pages 162-167.
Crossref
Jerome Custers, Denny Kim, Maarten Leyssen, Marc Gurwith, Frank Tomaka, James Robertson, Esther Heijnen, Richard Condit, Georgi Shukarev, Dirk Heerwegh, Roy van Heesbeen, Hanneke Schuitemaker, Macaya Douoguih, Eric Evans, Emily R. Smith & Robert T. Chen. (2021) Vaccines based on replication incompetent Ad26 viral vectors: Standardized template with key considerations for a risk/benefit assessment. Vaccine 39:22, pages 3081-3101.
Crossref
Mampe Masemola, Enoch Owusu-Sekyere, Abiodun A. Ogundeji, Hermias N. van Niekerk & Petronella Chaminuka. (2021) Farmers’ preference and willingness to pay for a multivalent lumpy skin disease and Rift Valley fever novel vaccine: A discrete choice experiment in the Free State province, South Africa. Preventive Veterinary Medicine 189, pages 105293.
Crossref
Gurumayum Suraj Sharma, Snigdha Krishna, Sheeza Khan, Tanveer A. Dar, Khurshid A. Khan & Laishram Rajendrakumar Singh. (2021) Protecting thermodynamic stability of protein: The basic paradigm against stress and unfolded protein response by osmolytes. International Journal of Biological Macromolecules 177, pages 229-240.
Crossref
Shitanshu Devrani, Rahul Tiwari, Naseef Khan, Krishnakumar Sankar, Shantanu Patil & K. Sridhar. (2021) Enhancing the insulation capability of a vaccine carrier box: An engineering approach. Journal of Energy Storage 36, pages 102182.
Crossref
Kendall B. Preston & Theodore W. Randolph. (2021) Stability of lyophilized and spray dried vaccine formulations. Advanced Drug Delivery Reviews 171, pages 50-61.
Crossref
Ravinder Kumar & Bhushan N. Kharbikar. (2021) Lyophilized yeast powder for adjuvant free thermostable vaccine delivery. Applied Microbiology and Biotechnology 105:8, pages 3131-3143.
Crossref
Agnieszka Razim, Marcelina Pyclik, Katarzyna Pacyga, Sabina Górska, Jintao Xu, Michal A. Olszewski, Andrzej Gamian & Andrzej Myc. (2021) Silicone Oil-Based Nanoadjuvants as Candidates for a New Formulation of Intranasal Vaccines. Vaccines 9:3, pages 234.
Crossref
Samuel M. Hanson, Shailbala Singh, Anthony Tabet, K. Jagannadha Sastry, Michael Barry & Chun Wang. (2021) Mucoadhesive wafers composed of binary polymer blends for sublingual delivery and preservation of protein vaccines. Journal of Controlled Release 330, pages 427-437.
Crossref
Jacob William Coffey, Gaurav Das Gaiha & Giovanni Traverso. (2021) Oral Biologic Delivery: Advances Toward Oral Subunit, DNA, and mRNA Vaccines and the Potential for Mass Vaccination During Pandemics. Annual Review of Pharmacology and Toxicology 61:1, pages 517-540.
Crossref
Christopher Mensch, Ramesh Chintala, Denise Nawrocki, Jeffrey T. Blue & Akhilesh Bhambhani. (2021) Enabling Lyophilized Pneumococcal Conjugate Vaccines Through Formulation Design and Excipient Selection Suitable for A Multivalent Adjuvanted Vaccine. Journal of Pharmaceutical Sciences 110:1, pages 97-107.
Crossref
Paulo Henrique Amorim Santos & Roberto Antonio Martins. 2021. Industrial Engineering and Operations Management. Industrial Engineering and Operations Management 253 264 .
Riyad F. Alzhrani, Haiyue Xu, Chaeho Moon, Laura J. Suggs, Robert O. WilliamsIIIIII & Zhengrong Cui. 2021. Vaccine Delivery Technology. Vaccine Delivery Technology 489 498 .
Xiao-xin Zuo, Yan-hong Zhao, Ming-xu Zhou, Bi-hua Deng, Lai-gen Hu, Fang Lv, Yu Lu & Ji-bo Hou. (2020) Live vaccine preserved at room temperature: Preparation and characterization of a freeze-dried classical swine fever virus vaccine. Vaccine 38:52, pages 8371-8378.
Crossref
Lei Tan, Guoyuan Wen, Yanmei Yuan, Meizhen Huang, Yingjie Sun, Ying Liao, Cuiping Song, Weiwei Liu, Yonghong Shi, Huabin Shao, Xusheng Qiu & Chan Ding. (2020) Development of a Recombinant Thermostable Newcastle Disease Virus (NDV) Vaccine Express Infectious Bronchitis Virus (IBV) Multiple Epitopes for Protecting against IBV and NDV Challenges. Vaccines 8:4, pages 564.
Crossref
Olufemi Samuel Folorunso & Olihile M. Sebolai. (2020) Overview of the Development, Impacts, and Challenges of Live-Attenuated Oral Rotavirus Vaccines. Vaccines 8:3, pages 341.
Crossref
Robert L. Garcea, Natalie M. Meinerz, Miao Dong, Hans Funke, Saba Ghazvini & Theodore W. Randolph. (2020) Single-administration, thermostable human papillomavirus vaccines prepared with atomic layer deposition technology. npj Vaccines 5:1.
Crossref
Mario Amacker, Charli Smardon, Laura Mason, Jack Sorrell, Kirk Jeffery, Michael Adler, Farien Bhoelan, Olga Belova, Mark Spengler, Beena Punnamoottil, Markus Schwaller, Olivia Bonduelle, Behazine Combadière, Toon Stegmann, Andrew Naylor, Richard Johnson, Desmond Wong & Sylvain Fleury. (2020) New GMP manufacturing processes to obtain thermostable HIV-1 gp41 virosomes under solid forms for various mucosal vaccination routes. npj Vaccines 5:1.
Crossref
Elizabeth A. Grego, Alaric C. Siddoway, Metin Uz, Luman Liu, John C. Christiansen, Kathleen A. Ross, Sean M. Kelly, Surya K. Mallapragada, Michael J. Wannemuehler & Balaji Narasimhan. 2021. Nanoparticles for Rational Vaccine Design. Nanoparticles for Rational Vaccine Design 29 76 .
Yijia Liu, Xianghui Zhu, Yan Lu, Xiaoli Wang, Chuangnian Zhang, Hongfan Sun & Guilei Ma. (2019) Antigen‐Inorganic Hybrid Flowers‐Based Vaccines with Enhanced Room Temperature Stability and Effective Anticancer Immunity. Advanced Healthcare Materials 8:21, pages 1900660.
Crossref
Zoë A. Campbell, Samuel M. Thumbi, Thomas L. Marsh, Marsha B. Quinlan, Gabriel M. Shirima & Guy H. Palmer. (2019) Why isn’t everyone using the thermotolerant vaccine? Preferences for Newcastle disease vaccines by chicken-owning households in Tanzania. PLOS ONE 14:8, pages e0220963.
Crossref
Jessica A. White & Manjari Lal. (2019) Technical product attributes in development of an oral enteric vaccine for infants. Vaccine 37:34, pages 4800-4804.
Crossref
Seyed Mohammad Gheibi Hayat & Majid Darroudi. (2019) Nanovaccine: A novel approach in immunization. Journal of Cellular Physiology 234:8, pages 12530-12536.
Crossref
Misbah Farooqui, Amir Sultan & Hassan Ahmed Khan. (2019) Thermostable Vaccines: Past, Present and Future Perspectives. Pakistan BioMedical Journal 2:1.
Crossref
Whitney Nicole Souery, Shreedevi Arun Kumar, Daniel Prasca-Chamorro, David Mitchell Moore, Jacob Good & Corey J. Bishop. (2019) Controlling and quantifying the stability of amino acid-based cargo within polymeric delivery systems. Journal of Controlled Release 300, pages 102-113.
Crossref
Ravinder Kumar & Piyush Kumar. (2019) Yeast-based vaccines: New perspective in vaccine development and application. FEMS Yeast Research 19:2.
Crossref
N. Dumpa, K. Goel, Yuhan Guo, H. McFall, Amit Raviraj Pillai, Ashay Shukla, M. A. Repka & S. Narasimha Murthy. (2019) Stability of Vaccines. AAPS PharmSciTech 20:2.
Crossref
Eduardo Ruiz-Hitzky, Margarita Darder, Bernd Wicklein, Fidel Antonio Castro-Smirnov & Pilar Aranda. (2019) CLAY-BASED BIOHYBRID MATERIALS FOR BIOMEDICAL AND PHARMACEUTICAL APPLICATIONS. Clays and Clay Minerals 67:1, pages 44-58.
Crossref
Chandana Kolluru, Yasmine Gomaa & Mark R. Prausnitz. (2018) Development of a thermostable microneedle patch for polio vaccination. Drug Delivery and Translational Research 9:1, pages 192-203.
Crossref
Yang Huijuan, Dai Xiaohu, Liu Ze, Cai Wei, Zhou Jian, Ma Lei, Song Shaohui, Li Weidong & Liao Guoyang. (2018) Role of phenol red in the stabilization of the Sabin type 2 inactivated polio vaccine at various pH values. Journal of Medical Virology 91:1, pages 22-30.
Crossref
Woo-Jin Shin, Daiki Hara, Francisca Gbormittah, Hana Chang, Byeong S. Chang & Jae U. Jung. (2018) Development of Thermostable Lyophilized Sabin Inactivated Poliovirus Vaccine. mBio 9:6.
Crossref
Ravinder Kumar. (2018) Investigating the long-term stability of protein immunogen(s) for whole recombinant yeast-based vaccines. FEMS Yeast Research 18:7.
Crossref
Fatima Yahiaoui, Moustafa Kardjadj, Younes Laidoudi, Hacène Medkour & Meriem Hind Ben-Mahdi. (2018) The epidemiology of dog rabies in Algeria: Retrospective national study of dog rabies cases, determination of vaccination coverage and immune response evaluation of three commercial used vaccines. Preventive Veterinary Medicine 158, pages 65-70.
Crossref
Gaurav Kanojia, René H.M. Raeven, Larissa van der Maas, Tim H.E. Bindels, Elly van Riet, Bernard Metz, Peter C. Soema, Rimko ten Have, Henderik W. Frijlink, Jean-Pierre Amorij & Gideon F.A. Kersten. (2018) Development of a thermostable spray dried outer membrane vesicle pertussis vaccine for pulmonary immunization. Journal of Controlled Release 286, pages 167-178.
Crossref
José Crecente-Campo, Silvia Lorenzo-Abalde, Azucena Mora, Juan Marzoa, Noemi Csaba, Jorge Blanco, África González-Fernández & María José Alonso. (2018) Bilayer polymeric nanocapsules: A formulation approach for a thermostable and adjuvanted E. coli antigen vaccine. Journal of Controlled Release 286, pages 20-32.
Crossref
Wei Qi, Scott Orgel, Alain Francon, Theodore W. Randolph & John F. Carpenter. (2018) Urea Improves Stability of Inactivated Polio Vaccine Serotype 3 During Lyophilization and Storage in Dried Formulations. Journal of Pharmaceutical Sciences 107:8, pages 2070-2078.
Crossref
Martinus A.H. Capelle, Lara Babich, J.P. Els van Deventer-Troost, Doris Salerno, Kelly Krijgsman, Ulrike Dirmeier, Britt Raaby & Janik Adriaansen. (2018) Stability and suitability for storage and distribution of Ad26.ZEBOV/MVA-BN®-Filo heterologous prime-boost Ebola vaccine. European Journal of Pharmaceutics and Biopharmaceutics 129, pages 215-221.
Crossref
Gaurav Kanojia, Rimko ten Have, Debbie Brugmans, Peter C. Soema, Henderik W. Frijlink, Jean-Pierre Amorij & Gideon Kersten. (2018) The effect of formulation on spray dried Sabin inactivated polio vaccine. European Journal of Pharmaceutics and Biopharmaceutics 129, pages 21-29.
Crossref
Lotty Evertje Duijzer, Willem van Jaarsveld & Rommert Dekker. (2018) Literature review: The vaccine supply chain. European Journal of Operational Research 268:1, pages 174-192.
Crossref
Stephany Y. Tzeng, Kevin J. McHughAdam M. BehrensSviatlana RoseJames L. SugarmanShiran FerberRobert Langer & Ana Jaklenec. (2018) Stabilized single-injection inactivated polio vaccine elicits a strong neutralizing immune response. Proceedings of the National Academy of Sciences 115:23.
Crossref
Ying Wan, John M. Hickey, Christopher Bird, Katey Witham, Paul Fahey, Angus Forster, Sangeeta B. Joshi & David B. Volkin. (2018) Development of Stabilizing Formulations of a Trivalent Inactivated Poliovirus Vaccine in a Dried State for Delivery in the Nanopatch™ Microprojection Array. Journal of Pharmaceutical Sciences 107:6, pages 1540-1551.
Crossref
Ashaben Patel, Steven M. Erb, Linda Strange, Ravi S. Shukla, Ozan S. Kumru, Lee Smith, Paul Nelson, Sangeeta B. Joshi, Jill A. Livengood & David B. Volkin. (2018) Combined semi-empirical screening and design of experiments (DOE) approach to identify candidate formulations of a lyophilized live attenuated tetravalent viral vaccine candidate. Vaccine 36:22, pages 3169-3179.
Crossref
Tina Comes, Kristin Bergtora Sandvik & Bartel Van de Walle. (2018) Cold chains, interrupted. Journal of Humanitarian Logistics and Supply Chain Management 8:1, pages 49-69.
Crossref
Didier Clénet. (2018) Accurate prediction of vaccine stability under real storage conditions and during temperature excursions. European Journal of Pharmaceutics and Biopharmaceutics 125, pages 76-84.
Crossref
Danielle A. Wagner-Muñiz, Shannon L. Haughney, Sean M. Kelly, Michael J. Wannemuehler & Balaji Narasimhan. (2018) Room Temperature Stable PspA-Based Nanovaccine Induces Protective Immunity. Frontiers in Immunology 9.
Crossref
Pilar Aranda, Margarita Darder, Bernd Wicklein, Giora Rytwo & Eduardo Ruiz‐Hitzky. 2018. Hybrid Organic‐Inorganic Interfaces. Hybrid Organic‐Inorganic Interfaces 1 84 .
Renata Chagas Bastos, Marilza Batista Corrêa, Iaralice Medeiros de Souza, Milton Neto da Silva, Denise da Silva Gomes Pereira, Fernanda Otaviano Martins, Camila da Silva Faria, Ana Paula Dinis Ano Bom, Maria de Lourdes Leal, Ellen Jessouroun, José Godinho da SilvaJr.Jr., Ricardo de Andrade Medronho & Ivna Alana Freitas Brasileiro da Silveira. (2017) Brazilian meningococcal C conjugate vaccine: physicochemical, immunological, and thermal stability characteristics. Glycoconjugate Journal 35:1, pages 3-13.
Crossref
Mark J. Papania, Darin Zehrung & Courtney Jarrahian. 2018. Plotkin's Vaccines. Plotkin's Vaccines 1320 1353.e17 .
Lothar Stitz, Annette Vogel, Margit Schnee, Daniel Voss, Susanne Rauch, Thorsten Mutzke, Thomas Ketterer, Thomas Kramps & Benjamin Petsch. (2017) A thermostable messenger RNA based vaccine against rabies. PLOS Neglected Tropical Diseases 11:12, pages e0006108.
Crossref
Vishal M. Toprani, Neha Sahni, John M. Hickey, George A. Robertson, C. Russell Middaugh, Sangeeta B. Joshi & David B. Volkin. (2017) Development of a candidate stabilizing formulation for bulk storage of a double mutant heat labile toxin (dmLT) protein based adjuvant. Vaccine 35:41, pages 5471-5480.
Crossref
Kevin J. McHugh, Thanh D. Nguyen, Allison R. Linehan, David Yang, Adam M. BehrensSviatlana Rose, Zachary L. Tochka, Stephany Y. Tzeng, James J. NormanAaron C. Anselmo, Xian XuStephanie Tomasic, Matthew A. Taylor, Jennifer LuRohiverth GuarecucoRobert Langer & Ana Jaklenec. (2017) Fabrication of fillable microparticles and other complex 3D microstructures. Science 357:6356, pages 1138-1142.
Crossref
M.S. Siva Sankar, V. Bhanuprakash, G. Venkatesan, D.P. Bora, M. Prabhu & R. Yogisharadhya. (2017) Comparative efficacy of chemical stabilizers on the thermostabilization of a novel live attenuated buffalopox vaccine. Biologicals 49, pages 39-45.
Crossref
Lien Lybaert, Keun Ah Ryu, Riet De Rycke, Alfred C. Chon, Olivier De Wever, Karim Y. Vermaelen, Aaron Esser-Kahn & Bruno G. De Geest. (2017) Polyelectrolyte-Enrobed Cancer Cells in View of Personalized Immune-Therapy. Advanced Science 4:6, pages 1700050.
Crossref
Seo Young Cho, Hyoung Jin Kim, Nguyen Thi Lan, Hyun-Ja Han, Deok-Chan Lee, Jee Youn Hwang, Mun-Gyeong Kwon, Bo Kyu Kang, Sang Yoon Han, Hyoungjoon Moon, Hyun Ah Kang & Hong-Jin Kim. (2017) Oral vaccination through voluntary consumption of the convict grouper Epinephelus septemfasciatus with yeast producing the capsid protein of red-spotted grouper nervous necrosis virus. Veterinary Microbiology 204, pages 159-164.
Crossref
Sameer P. Naik, Jagdish K. Zade, Rajendra N. Sabale, Sambhaji S. Pisal, Ravi Menon, Subhash G. Bankar, Sunil Gairola & Rajeev M. Dhere. (2017) Stability of heat stable, live attenuated Rotavirus vaccine (ROTASIIL®). Vaccine 35:22, pages 2962-2969.
Crossref
Robert P. Lavan, Alasdair I. MacG. King, David J. Sutton & Kaan Tunceli. (2017) Rationale and support for a One Health program for canine vaccination as the most cost-effective means of controlling zoonotic rabies in endemic settings. Vaccine 35:13, pages 1668-1674.
Crossref
Alexander Flood, Marcus Estrada, David McAdams, Yuhua Ji & Dexiang Chen. (2016) Development of a Freeze-Dried, Heat-Stable Influenza Subunit Vaccine Formulation. PLOS ONE 11:11, pages e0164692.
Crossref
Herve Caspard, Kathleen L. Coelingh, Raburn M. Mallory & Christopher S. Ambrose. (2016) Association of vaccine handling conditions with effectiveness of live attenuated influenza vaccine against H1N1pdm09 viruses in the United States. Vaccine 34:42, pages 5066-5072.
Crossref
Stephany Y. Tzeng, Rohiverth Guarecuco, Kevin J. McHugh, Sviatlana Rose, Evan M. Rosenberg, Yingying Zeng, Robert Langer & Ana Jaklenec. (2016) Thermostabilization of inactivated polio vaccine in PLGA-based microspheres for pulsatile release. Journal of Controlled Release 233, pages 101-113.
Crossref
Nitesh K. Kunda, Denis Wafula, Meilinn Tram, Terry H. Wu & Pavan Muttil. (2016) A stable live bacterial vaccine. European Journal of Pharmaceutics and Biopharmaceutics 103, pages 109-117.
Crossref
Sharmeen Nishat & Peter Andreana. (2016) Entirely Carbohydrate-Based Vaccines: An Emerging Field for Specific and Selective Immune Responses. Vaccines 4:2, pages 19.
Crossref
Sugandha Saboo, Ebenezer Tumban, Julianne Peabody, Denis Wafula, David S. Peabody, Bryce Chackerian & Pavan Muttil. (2016) Optimized Formulation of a Thermostable Spray-Dried Virus-Like Particle Vaccine against Human Papillomavirus. Molecular Pharmaceutics 13:5, pages 1646-1655.
Crossref
Leonard Y. Chu, Ling Ye, Ke Dong, Richard W. Compans, Chinglai Yang & Mark R. Prausnitz. (2015) Enhanced Stability of Inactivated Influenza Vaccine Encapsulated in Dissolving Microneedle Patches. Pharmaceutical Research 33:4, pages 868-878.
Crossref
Debra D. Kristensen, Tina Lorenson, Kate Bartholomew & Shirley Villadiego. (2016) Can thermostable vaccines help address cold-chain challenges? Results from stakeholder interviews in six low- and middle-income countries. Vaccine 34:7, pages 899-904.
Crossref
Kevin R. Trabbic, Jean-Paul Bourgault, Mengchao Shi, Matthew Clark & Peter R. Andreana. (2016) Immunological evaluation of the entirely carbohydrate-based Thomsen-Friedenreich – PS B conjugate. Organic & Biomolecular Chemistry 14:13, pages 3350-3355.
Crossref
Hangyu Zhou, Guangchuan Wang, Xiao-Feng Li, Yaling Li, Shun-Ya Zhu, Cheng-Feng Qin & Ruikang Tang. (2016) Alumina-encapsulated vaccine formulation with improved thermostability and immunogenicity. Chemical Communications 52:38, pages 6447-6450.
Crossref
R. Ramírez, A.I. Sanz, P. Bach, M. Alseda & P. Godoy. (2016) Cadena del frío de las vacunas y conocimientos de los profesionales: análisis de la situación en la Región Sanitaria de Lleida. Vacunas 17:1, pages 11-17.
Crossref
Tao Sun, Huifang Han, Gregory A. Hudalla, Yi Wen, Rebecca R. Pompano & Joel H. Collier. (2016) Thermal stability of self-assembled peptide vaccine materials. Acta Biomaterialia 30, pages 62-71.
Crossref
Xinyuan Chen, Ji Wang, Jeffrey H. Wu & Mei X. Wu. 2016. Biologics to Treat Substance Use Disorders. Biologics to Treat Substance Use Disorders 309 325 .
John H Carra, Karen A O Martins, Rowena D Schokman, Camenzind G Robinson, Jesse T Steffens & Sina Bavari. (2015) A thermostable, chromatographically purified Ebola nano-VLP vaccine. Journal of Translational Medicine 13:1.
Crossref
C.S. Kyriakis. (2015) Tomorrow’s vector vaccines for small ruminants. Veterinary Microbiology 181:1-2, pages 47-52.
Crossref
Yankai Fu, Yanzhuo Wu, Yuping Wei, Xianhua Chen, Jiandong Xu & Xia Xu. (2015) Development of a thermally stable formulation for l -asparaginase storage in aqueous conditions. Journal of Molecular Catalysis B: Enzymatic 122, pages 8-14.
Crossref
Kevin J. McHugh, Rohiverth Guarecuco, Robert Langer & Ana Jaklenec. (2015) Single-injection vaccines: Progress, challenges, and opportunities. Journal of Controlled Release 219, pages 596-609.
Crossref
L.J.J. Hansen, R. Daoussi, C. Vervaet, J.-P. Remon & T.R.M. De Beer. (2015) Freeze-drying of live virus vaccines: A review. Vaccine 33:42, pages 5507-5519.
Crossref
Durlav Prasad Bora, Veerakyathappa Bhanupraka, Gnanavel Venkatesan, Vinayagamurthy Balamuruga, Manimuthu Prabhu & Revanaiah Yogisharad. (2015) Effect of Stabilization and Reconstitution on the Stability of a Novel Strain of Live Attenuated Orf Vaccine (ORFV MUK59/05). Asian Journal of Animal and Veterinary Advances 10:8, pages 365-375.
Crossref
Christopher L. Karp, Deborah Lans, José Esparza, Eleanore B. Edson, Katey E. Owen, Christopher B. Wilson, Penny M. Heaton, Orin S. Levine & Raja Rao. (2015) Evaluating the value proposition for improving vaccine thermostability to increase vaccine impact in low and middle-income countries. Vaccine 33:30, pages 3471-3479.
Crossref
Ebenezer Tumban, Pavan Muttil, Carolina Andrea A. Escobar, Julianne Peabody, Denis Wafula, David S. Peabody & Bryce Chackerian. (2015) Preclinical refinements of a broadly protective VLP-based HPV vaccine targeting the minor capsid protein, L2. Vaccine 33:29, pages 3346-3353.
Crossref
Nikolas T. Weissmueller, Heiko A. Schiffter, Robert C. Carlisle, Christine S. Rollier & Andrew J. Pollard. (2015) Needle-Free Dermal Delivery of a Diphtheria Toxin CRM 197 Mutant on Potassium-Doped Hydroxyapatite Microparticles . Clinical and Vaccine Immunology 22:5, pages 586-592.
Crossref
Xinran Li, Sachin G. Thakkar, Tinashe B. Ruwona, Robert O. WilliamsIIIIII & Zhengrong Cui. (2015) A method of lyophilizing vaccines containing aluminum salts into a dry powder without causing particle aggregation or decreasing the immunogenicity following reconstitution. Journal of Controlled Release 204, pages 38-50.
Crossref
Jeffrey T. Blue, Jessica R. Sinacola & Akhilesh Bhambhani. 2015. Lyophilized Biologics and Vaccines. Lyophilized Biologics and Vaccines 179 210 .
Liuquan Chang, Jeffrey T. Blue, Joseph Schaller, Lynn Phelan, Lakshmi Khandke & Bruce A. Green. 2015. Quality by Design for Biopharmaceutical Drug Product Development. Quality by Design for Biopharmaceutical Drug Product Development 437 473 .
John W. Cherwonogrodzky, Nicole D. Barabé, Michelle L. Grigat, William E. Lee, Robert T. Poirier, Scott J. Jager & Bradley J. Berger. (2014) Thermostable Cross-Protective Subunit Vaccine against Brucella Species. Clinical and Vaccine Immunology 21:12, pages 1681-1688.
Crossref
Changcheng Zhu, Yoko Shoji, Scott McCray, Michael Burke, Caitlin E. Hartman, Jessica A. Chichester, Jeff Breit, Vidadi Yusibov, Dexiang Chen & Manjari Lal. (2014) Stabilization of HAC1 Influenza Vaccine by Spray Drying: Formulation Development and Process Scale-Up. Pharmaceutical Research 31:11, pages 3006-3018.
Crossref
Tara D. Sutherland, Alagacone Sriskantha, Jeffrey S. Church, Tanja Strive, Holly E. Trueman & Tsunenori Kameda. (2014) Stabilization of Viruses by Encapsulation in Silk Proteins. ACS Applied Materials & Interfaces 6:20, pages 18189-18196.
Crossref
Xinyuan Chen, Garuna Kositratna, Chang Zhou, Dieter Manstein & Mei X. Wu. (2014) Micro-fractional epidermal powder delivery for improved skin vaccination. Journal of Controlled Release 192, pages 310-316.
Crossref
Heleen Kraan, Paul van Herpen, Gideon Kersten & Jean-Pierre Amorij. (2014) Development of Thermostable Lyophilized Inactivated Polio Vaccine. Pharmaceutical Research 31:10, pages 2618-2629.
Crossref
Didier Clénet, Frédéric Imbert, Patricia Probeck, Nausheen Rahman & Salvador F. Ausar. (2014) Advanced Kinetic Analysis as a Tool for Formulation Development and Prediction of Vaccine Stability. Journal of Pharmaceutical Sciences 103:10, pages 3055-3064.
Crossref
. (2014) Enhancing the Work of the Department of Health and Human Services National Vaccine Program in Global Immunization: Recommendations of the National Vaccine Advisory Committee. Public Health Reports 129:5_suppl3, pages 12-85.
Crossref
Ozan S. Kumru, Sangeeta B. Joshi, Dawn E. Smith, C. Russell Middaugh, Ted Prusik & David B. Volkin. (2014) Vaccine instability in the cold chain: Mechanisms, analysis and formulation strategies. Biologicals 42:5, pages 237-259.
Crossref
Sunali Bhatnagar, Heiko Schiffter & Constantin-C. Coussios. (2014) Exploitation of Acoustic Cavitation-Induced Microstreaming to Enhance Molecular Transport. Journal of Pharmaceutical Sciences 103:6, pages 1903-1912.
Crossref
M. Prabhu, V. Bhanuprakash, G. Venkatesan, R. Yogisharadhya, D.P. Bora & V. Balamurugan. (2014) Evaluation of stability of live attenuated camelpox vaccine stabilized with different stabilizers and reconstituted with various diluents. Biologicals 42:3, pages 169-175.
Crossref
Elena Canali, Angelo Bolchi, Gloria Spagnoli, Hanna Seitz, Ivonne Rubio, Thelma A. Pertinhez, Martin Müller & Simone Ottonello. (2014) A high-performance thioredoxin-based scaffold for peptide immunogen construction: proof-of-concept testing with a human papillomavirus epitope. Scientific Reports 4:1.
Crossref
Wei Qi, Yuhong Zeng, Scott Orgel, Alain Francon, Jae Hyun Kim, Theodore W. Randolph, John F. Carpenter & C. Russell Middaugh. (2014) Preformulation Study of Highly Purified Inactivated Polio Vaccine, Serotype 3. Journal of Pharmaceutical Sciences 103:1, pages 140-151.
Crossref
Manoj V MurhekarSrihari DuttaAmbujam Nair KapoorSailaja BitraguntaRaja DodumPramit GhoshKarumanagounder Kolanda SwamyKalyanranjan MukhopadhyaySomorjit NingombamKamlesh ParmarDevegowda RavishankarBalraj SinghVarsha SinghRajesh SisodiyaRamaratnam SubramanianTana Takum. (2013) Frequent exposure to suboptimal temperatures in vaccine cold-chain system in India: results of temperature monitoring in 10 states. Bulletin of the World Health Organization 91:12, pages 906-913.
Crossref
Jérôme Ateudjieu, Bruno Kenfack, Blaise Wakam Nkontchou & Maurice Demanou. (2013) Program on immunization and cold chain monitoring: the status in eight health districts in Cameroon. BMC Research Notes 6:1.
Crossref
Eduardo Ruiz-Hitzky, Margarita Darder, Francisco M. Fernandes, Bernd Wicklein, Ana C.S. Alcântara & Pilar Aranda. (2013) Fibrous clays based bionanocomposites. Progress in Polymer Science 38:10-11, pages 1392-1414.
Crossref
Kimberly J. Hassett, Megan C. Cousins, Lilia A. Rabia, Chrystal M. Chadwick, Joanne M. O’Hara, Pradyot Nandi, Robert N. Brey, Nicholas J. Mantis, John F. Carpenter & Theodore W. Randolph. (2013) Stabilization of a recombinant ricin toxin A subunit vaccine through lyophilization. European Journal of Pharmaceutics and Biopharmaceutics 85:2, pages 279-286.
Crossref
Frances E. Pearson, Celia L. McNeilly, Michael L. Crichton, Clare A. Primiero, Sally R. Yukiko, Germain J. P. Fernando, Xianfeng Chen, Sarah C. Gilbert, Adrian V. S. Hill & Mark A. F. Kendall. (2013) Dry-Coated Live Viral Vector Vaccines Delivered by Nanopatch Microprojections Retain Long-Term Thermostability and Induce Transgene-Specific T Cell Responses in Mice. PLoS ONE 8:7, pages e67888.
Crossref
Alaina J Mooney & S Mark Tompkins. (2013) Experimental vaccines against potentially pandemic and highly pathogenic avian influenza viruses. Future Virology 8:1, pages 25-41.
Crossref
Dexiang Chen & Darin Zehrung. (2013) Desirable Attributes of Vaccines for Deployment in Low-Resource Settings. Journal of Pharmaceutical Sciences 102:1, pages 29-33.
Crossref
Bruce Y. Lee, Brigid E. Cakouros, Tina-Marie Assi, Diana L. Connor, Joel Welling, Souleymane Kone, Ali Djibo, Angela R. Wateska, Lionel Pierre & Shawn T. Brown. (2012) The impact of making vaccines thermostable in Niger's vaccine supply chain. Vaccine 30:38, pages 5637-5643.
Crossref
Jeney Zhang, Eleanor Pritchard, Xiao Hu, Thomas Valentin, Bruce Panilaitis, Fiorenzo G. Omenetto & David L. Kaplan. (2012) Stabilization of vaccines and antibiotics in silk and eliminating the cold chain. Proceedings of the National Academy of Sciences 109:30, pages 11981-11986.
Crossref
Jean-Pierre Amorij, Gideon F.A. Kersten, Vinay Saluja, Wouter F. Tonnis, Wouter L.J. Hinrichs, Bram Slütter, Suzanne M. Bal, Joke A. Bouwstra, Anke Huckriede & Wim Jiskoot. (2012) Towards tailored vaccine delivery: Needs, challenges and perspectives. Journal of Controlled Release 161:2, pages 363-376.
Crossref
Naveen Kanthamneni, Sadhana Sharma, Samantha A. Meenach, Beau Billet, Ji-Cheng Zhao, Eric M. Bachelder & Kristy M. Ainslie. (2012) Enhanced stability of horseradish peroxidase encapsulated in acetalated dextran microparticles stored outside cold chain conditions. International Journal of Pharmaceutics 431:1-2, pages 101-110.
Crossref
Daisy Higginson, Evropi Theodoratou, Harish Nair, Tanvir Huda, Lina Zgaga, Suresh S Jadhav, Saad B Omer, Igor Rudan & Harry Campbell. (2011) An evaluation of respiratory administration of measles vaccine for prevention of acute lower respiratory infections in children. BMC Public Health 11:S3.
Crossref
James Chesko, Chris Fox, Tim Dutill, Thomas Vedvick & Steve Reed. 2011. Development of Vaccines. Development of Vaccines 385 397 .
Alexander Marin & Alexander K. Andrianov. (2011) Carboxymethylcellulose–Chitosan‐coated microneedles with modulated hydration properties. Journal of Applied Polymer Science 121:1, pages 395-401.
Crossref
Jeremy M. Luke, Aaron E. Carnes, Ping Sun, Clague P. Hodgson, David S. Waugh & James A. Williams. (2011) Thermostable tag (TST) protein expression system: Engineering thermotolerant recombinant proteins and vaccines. Journal of Biotechnology 151:3, pages 242-250.
Crossref
D. Chen, S. Kapre, A. Goel, K. Suresh, S. Beri, J. Hickling, J. Jensen, M. Lal, J.M. Preaud, M. LaForce & D. Kristensen. (2010) Thermostable formulations of a hepatitis B vaccine and a meningitis A polysaccharide conjugate vaccine produced by a spray drying method. Vaccine 28:31, pages 5093-5099.
Crossref
Brian R. Sloat, Michael A. Sandoval & Zhengrong Cui. (2010) Towards preserving the immunogenicity of protein antigens carried by nanoparticles while avoiding the cold chain. International Journal of Pharmaceutics 393:1-2, pages 198-203.
Crossref
Sandra S. Renteria, Courtney C. Clemens & Maria A. Croyle. (2010) Development of a nasal adenovirus-based vaccine: Effect of concentration and formulation on adenovirus stability and infectious titer during actuation from two delivery devices. Vaccine 28:9, pages 2137-2148.
Crossref
D. Kristensen & M. Zaffran. (2010) Designing vaccines for developing-country populations: ideal attributes, delivery devices, and presentation formats. Procedia in Vaccinology 2:2, pages 119-123.
Crossref
Stef Lemmens, Mauro Bernuzzi & Amir Reichman. (2016) Performance Measurement of a Rotavirus Vaccine Supply Chain Design by the Integration of Production Capacity into the Guaranteed Service Approach. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.